Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / PIRS - Pieris Pharmaceuticals Inc. (PIRS) CEO Stephen Yoder on Q4 2021 Results - Earnings Call Transcript

PIRS - Pieris Pharmaceuticals Inc. (PIRS) CEO Stephen Yoder on Q4 2021 Results - Earnings Call Transcript

Pieris Pharmaceuticals Inc.
Pieris Pharmaceuticals, Inc. (PIRS) Q4 2021 Earnings Conference Call March 01, 2022, 08:00 ET Company Participants Stephen Yoder - CEO, President & Director Thomas Bures - SVP & CFO Shane Olwill - SVP & Chief Development Officer Conference Call Participants Jonathan Miller - Evercore ISI Matthew Phipps - William Blair & Company Roger Song - Jefferies Presentation Operator Greetings, and welcome to the Pieris Pharmaceuticals Year-End Earnings Call. [Operator Instructions]. As a reminder, this conference is being recorded. I would now like to turn the call over to Tom Bures, Chief Financial Officer. Thank you. You may begin. Thomas Bures Thank you. Good morning, everyone, and thank you for joining us for our year-end 2021 conference call and corporate update. On the call today, we have Steve Yoder, our President and CEO, who will provide a corporate overview and outlook on our pipeline; Tim Demuth, our Chief Medical Officer; Hitto

For further details see:

Pieris Pharmaceuticals, Inc. (PIRS) CEO Stephen Yoder on Q4 2021 Results - Earnings Call Transcript
Stock Information
Company Name: Pieris Pharmaceuticals Inc.
Stock Symbol: PIRS
Market: NASDAQ
Website: pieris.com
Menu
PIRS PIRS Quote PIRS Short PIRS News PIRS Articles PIRS Message Board
Get PIRS Alerts

News, Short Squeeze, Breakout and More Instantly...